Articles with "ido1 expression" as a keyword



Photo by ospanali from unsplash

Indoleamine 2,3-dioxygenase expression in the prognosis of the localized prostate cancer

Sign Up to like & get
recommendations!
Published in 2020 at "International Urology and Nephrology"

DOI: 10.1007/s11255-020-02414-0

Abstract: Background Indoleamine 2,3-dioxygenase (IDO1) is an enzyme that acts as an immunomodulatory molecule. It is found in several types of cancer where it seems to be associated with tumor escape due to its immunosuppressive mechanisms.… read more here.

Keywords: prostate; recurrence; ido1 expression; expression ... See more keywords
Photo from wikipedia

Characterization of the temporal, cell-specific and interferon-inducible patterns of indoleamine 2,3 dioxygenase 1 (IDO1) expression in the human placenta across gestation.

Sign Up to like & get
recommendations!
Published in 2021 at "Placenta"

DOI: 10.1016/j.placenta.2021.09.008

Abstract: INTRODUCTION The human placenta performs multiple functions necessary for successful pregnancy, but the metabolic pathways and molecular mechanisms responsible for regulating placental development and functions remain incompletely understood. Catabolism of the essential amino acid tryptophan… read more here.

Keywords: expression human; human placenta; ido1 expression; expression ... See more keywords
Photo from wikipedia

Carbidopa, an activator of aryl hydrocarbon receptor, suppresses IDO1 expression in pancreatic cancer and decreases tumor growth

Sign Up to like & get
recommendations!
Published in 2022 at "Biochemical Journal"

DOI: 10.1042/bcj20210851

Abstract: IDO1 is an immunomodulatory enzyme responsible for tryptophan catabolism. Its expression in immune cells, especially the DCs, has attracted attention because it leads to tryptophan depletion at the immunological synapse, thereby causing T-cell anergy and… read more here.

Keywords: tumor growth; expression; ido1 expression; cancer ... See more keywords
Photo by paipai90 from unsplash

Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance.

Sign Up to like & get
recommendations!
Published in 2017 at "Cancer immunology research"

DOI: 10.1158/2326-6066.cir-16-0400

Abstract: Tumors use various mechanisms to avoid immune destruction. Cyclooxygenase-2 (COX-2) expression may be a driver of immune suppression in melanoma, but the mechanisms involved remain elusive. Here, we show that COX-2 expression drives constitutive expression… read more here.

Keywords: expression human; ido1 expression; constitutive ido1; expression ... See more keywords